Article Details

Achillion Pharmaceuticals (ACHN) Downgraded by Barclays to “Underweight”

Retrieved on: 2019-05-18 21:30:00

Tags for this article:

Click the tags to see associated articles and topics

Achillion Pharmaceuticals (ACHN) Downgraded by Barclays to “Underweight”. View article details on hiswai:

Excerpt

<div><b>Two Sigma Investments</b> LP lifted its holdings in Achillion Pharmaceuticals by 2,305.8% in the 4th quarter. <b>Two Sigma Investments</b> LP now owns ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up